Center for Applied Genomics

Today's Research Becomes Tomorrows Cure

Home
Home
About Us
About Us
- Our Team
  Our Team
- Our Mission
  Our Mission
- Publications
  Publications
- Search
  Search
CAG Services
CAG Services
- For Researchers
  For Researchers
- Pricing and Services
  Pricing and Services
- Our Technology
  Our Technology
- Downloads (CAG Forms and Software)
  Downloads (CAG Forms and Software)
- Polygenic Risk (IHCC)
  Polygenic Risk (IHCC)
- COVID-19 Survey (Test)
  COVID-19 Survey (Test)
- Sample Browser
  Sample Browser
CAG Studies
CAG Studies
- Disease Studies
  Disease Studies
- ADHD
  ADHD
- Asthma and Autoimmune Diseases
  Asthma and Autoimmune Diseases
- Autism
  Autism
- Cancers and Tumors
  Cancers and Tumors
- IBD - Crohn's Disease and Ulcerative Colitis
  IBD - Crohn's Disease and Ulcerative Colitis
- Rare Diseases
  Rare Diseases
For Participants
For Participants
- For Participants
  For Participants
- What's involved?
  What's involved?
- FAQs
  FAQs
- Resources and Genetics Info
  Resources and Genetics Info
Media
Media
- Media
  Media
- CAG in the Press
  CAG in the Press
- Privacy Policies
  Privacy Policies
Support CAG
Support CAG
- Pediatric Cancer
  Pediatric Cancer
- Psychiatric Disorders
  Psychiatric Disorders
- Rare Disease Program
  Rare Disease Program

Collaboration will bring together the premier pediatric genomics research organization, Center for Applied Genomics (CAG), with ex vivo gene therapy innovator, Medgenics.
Article by: GlobeNewswire; November 12, 2014

CAG in the Press

Center for Applied Genomics

Media

Medgenics Announces Rare & Orphan Disease Research Collaboration With The Children's Hospital of Philadelphia